Objective-To investigate in women older than 60 whether aortic stiffness or pulse pressure (PP) is associated with selected procoagulant or anticoagulant factors and to examine whether pulsatile stretch influences these factors in human vascular smooth muscle cells (VSMCs) in vitro. Methods and Results-Aortic pulse wave velocity (PWV) and carotid PP were studied in 123 apparently healthy postmenopausal women. PWV, PP, von Willebrand factor, and free tissue factor pathway inhibitor (TFPI), but not mean arterial pressure, increased with age. Free TFPI and PWV were positively correlated, even after adjustment for age and PP and other confounding parameters. In vitro, 5% or 10% pulsatile stretch (at 1 Hz) enhanced TFPI synthesis and secretion by VSMCs in a time-independent manner (1 to 48 hours) without changes in protein level of smooth muscle myosin heavy chain. Application of 5% static stretch had no effect. Conclusion-In postmenopausal women, free TFPI increases as vascular wall function deteriorates and PP increases.
A rterial stiffness, pulse pressure (PP), and a prothrombotic state are different vascular parameters that all increase consistently with age and are observed mainly in old people. Pulse wave velocity (PWV) and PP, 2 classical markers of arterial stiffness, and fibrinogen, 1 of the major coagulation proteins, are powerful and independent predictors of cardiovascular (CV) risk. [1] [2] [3] [4] [5] Such findings suggest that, in the elderly, consistent pathophysiological links are present among arterial stiffness, PP and coagulation. A causal relationship of these parameters might be even suspected in situations where a prothrombotic state and CV disease (such as in coronary heart disease or arterial thrombosis) are associated with increased stiffness and respond positively to anticoagulation treatment. 6 -8 Nevertheless, such observations remain scarce in the literature, and the relationship of age, arterial stiffness, and coagulation factors has not been investigated within a single population.
The geometric and hemodynamic features of a cylindrical arterial vessel are relatively easy to determine using noninvasive measurements. The vascular wall acts as an anticoagulant blood container and requires the separate study of various compounds, which are classified either as procoagulant (such as von Willebrand factor [vWF] ) or anticoagulant (such as free tissue factor pathway inhibitor [TFPI] ). 9 It is well recognized that endothelium-mediated functions are modulated by hemodynamic forces, including shear stress and pulsatile pressure, which cause changes in intracellular mechanics and mechanotransduction (reviewed by Chien 10 ). Although the role of shear stress on changes in antithrombotic and prothrombotic activities of endothelium has been extensively studied, scarce and controversial findings have been reported on the effects of pulsatile pressure on these functions. 11, 12 It has previously been established that increased circulating vWF is consistently associated with endothelial dysfunction. 13 Although high TFPI might also indicate endothelial dysfunction, 14 recent work has suggested that TFPI levels in medial vascular smooth muscle cells (VSMCs) may serve primarily to prevent arterial thrombosis and even intimal hyperplasia. 15 Whether pulsatile hemodynamic stress and PWV may influence circulating levels of these factors with advancing age remains to be investigated. This can be attempted by using an in vitro cellular test designed to explore intravascular TFPI and vWF synthesis and release under pulsatile conditions as close as possible to those in vivo.
A cohort of postmenopausal women represents a homogeneous human model in which an increase in arterial stiffness is associated with both changes in vascular wall status and the presence of a hypercoagulable state. 16 In postmenopausal women, PWV is increased to the same level as that of men of the same age and blood pressure, whereas carotid wave reflections are consistently higher than in men. A prothrombotic state is frequently observed in older women, in association with fluctuations in estrogenic hormone levels related to menopause and hormone replacement therapy (HRT). Therefore, the primary objective of this study was to investigate clinically, in postmenopausal women aged Ͼ60 years and not having experienced any CV event, the relationship of arterial stiffness and PP with selected procoagulant and anticoagulant factors, such as vWF antigen, factor VIII, fibrinogen, TFPI, soluble endothelial protein C receptor, soluble thrombomodulin, and total protein S. To explain the link of arterial stiffness, pulsatile hemodynamics, and coagulation, the second objective of our study was to examine the in vitro response of human vascular cells to mechanical stretch with respect to vWF and TFPI expression and release.
Methods

Study Population
The ARTEOS study is a cross-sectional study of 123 postmenopausal women volunteers recruited between March 2006 and January 2007 by means of information posters displayed in outpatient waiting rooms of the Department of Endocrinology, Nancy Hospital, and the Department of Health and Prevention, Luxembourg. Inclusion criteria were age greater than 60 years and the absence of target organ damage, including any clinically significant CV disease and atrial fibrillation. Women were excluded for the following reasons: contraindications to performing blood sampling or measurements of arterial wall structure and function. The regional ethics board approved the study protocol; all eligible women gave signed informed consent. All CV and coagulation parameters, as well as the biological active estradiol plasma level, were recorded in the Nancy Hospital and Institut National de la Santé et de la Recherche Médicale U961.
CV Measurements
Brachial blood pressure and heart rate were measured with a validated automatic device (DINAMAP 400Pro) after at least 10 minutes of rest in a quiet room and constant temperature. PP was calculated by subtracting diastolic blood pressure (DBP) from systolic blood pressure (SBP), and mean arterial pressure (MAP) was calculated by adding one-third PP to DBP. Assessment of arterial stiffness by PWV and central (carotid) blood pressure was obtained by applanation tonometry of the common carotid and femoral arteries using the PulsePen device as previously described and validated. 17 The variation coefficients of the interobserver and intraobserver reproducibility for the PulsePen were 7.9% and 7.2%, respectively. PP amplification was obtained from the ratio between brachial PP and carotid PP. High resolution B-mode ultrasound was used to measure intima-media thickness across 1-cm segments of the near and far walls of the common carotid artery 2 to 3 cm proximal to the bifurcation on both right and left sides. Carotid arterial radius was measured at the same time. The circumferential wall stress () was calculated according to the Laplace's law with the following equation: ϭ(2LCSAϫP)/MCSA, where LCSA is the lumen cross-sectional area, P is the pressure, and MCSA is the medial cross-sectional area.
Hemostatic Variables and Endothelial Markers
All measurements were performed with platelet-poor plasma obtained from venous blood drawn into 0.106 mol/L sodium citrate (9:1 vol/vol) by double centrifugation at 1750g for 10 minutes. Soluble thrombomodulin, soluble endothelial protein C receptor, total and free TFPI, vWF antigen, and D-dimers were measured by ELISA kits (Asserachrom, Diagnostica Stago, Asnières, France). Thrombinantithrombin complexes were measured by ELISA (Dade Behring, Marburg, Germany). Fibrinogen was measured by a Clauss assay with bovine thrombin from Biomérieux (Durham, NC). Coagulation factor VIII was measured by a 1-stage method using factor VIII-deficient plasma (Dade Behring) and an activated partial thromboplastin time reagent with kaolin as contact phase activator (CK Prest, Diagnostica Stago). The activated protein C-dependent anticoagulant function of protein S was determined using the STA-Staclot Protein S kit (Diagnostica Stago). Soluble CD146 was also assayed using a kit (Cy-Quant ELISA) from Biocytex (Marseille, France).
Cell Culture and Stretch
Clonetics human VSMCs and aortic endothelial cells (ECs) from Lonza (Basel, Switzerland) were used at passages 4 to 8. Studies were conducted on VSMCs grown to subconfluence in Clonetics Smooth Muscle Growth Medium-2 and EC in Clonetics Endothelial Cell Growth Medium-2, followed by serum withdrawal (with the FBS decreased to 0.5%) for 1 day to achieve quiescence. For stretch experiments, cells were seeded at 6ϫ10 5 cells/well on 6-well collagen-coated silicone elastomer-bottomed plates. Cells were subjected to either cyclic stretch (equiaxial stretch of 5% or 10% at a frequency of 1 Hz) or 5% static stretch in a FX-4000T Flexercell Strain Unit (Flexcell). Cells cultured without stretch were used as a control. At various times (1, 6, 24, and 48 hours), conditioned medium was collected for measurement of total and free TFPI secreted. Cell extracts were obtained by lysing VSMCs or ECs in complete Lysis-M buffer (Roche Diagnostics Corporation, Basel, Switzerland). Total and free TFPI and vWF synthesis and release by these cells were measured by ELISA and expressed per mL of conditioned medium or per mg of cell proteins. Total RNA was isolated from the VSMCs or ECs with the RNeasy Mini kit (Qiagen). The first-strand cDNA and polymerase chain reaction analysis were then performed as previously described. 18 Primer sequences are listed in the Supplemental Data, available online at http://atvb.ahajournals.org.
Statistical Analysis
Clinical data are presented as meansϮSD and in vitro data as meansϮSEM. HRT effects were analyzed by the Student t test. Relationships between continuous variables were determined using Pearson correlation coefficients. The association between age tertiles and CV or hemostatic parameters was tested using a trend test analysis of variance. Multiple linear regression analysis was used to identify the best independent predictors of free TFPI and vWF. We repeated our analyses with adjustments for potential confounders (carotid PP, fibrinogen, risk factors, or treatments). TFPI and vWF expressions in cell biology experiments were analyzed by the Student t test. Statistical analysis was performed using NCSS 2004 software package. Probability values Ͻ0.05 were considered significant.
Results
Patient Characteristics
Subjects were divided into 3 tertiles according to age. Table 1 indicates a slight, nonsignificant increase in brachial and carotid SBP and a similar decrease in DBP with age. Brachial and carotid PP were highly significantly different among the 3 tertiles. Significant increases with age were observed for carotid wall thickness, internal diameter, and especially PWV. MAP did not differ among tertiles. Blood pressure was normal in 100 subjects (SBP Ͻ140 mm Hg and DBP Ͻ90 mm Hg), and elevated (140 Ն SBP Ͻ190 mm Hg whatever DBP may be) in 23 subjects. There was no difference in heart rate and circumferential wall stress among the 3 tertiles, but there was a trend toward an attenuation of PP amplification with age. The distribution of CV risk factors and drug treatments differed significantly among the 3 tertiles except for body mass index and treatments for hypertension. Forty-four subjects were on antihypertensive therapy, including diuretics, ␤-blockers, calcium channel blockers, or blockers of the renin-angiotensin system. Fifty-four subjects were past and 22 were current HRT users (4 oral and 18 transdermal HRT). Biologically active estradiol plasma levels ranged from 4 to 370 pg/mL in current users and from 2 to 64 pg/mL in women receiving no therapy.
As classically observed, several coagulation and endothelial variables were positively associated with age: factor VIII, vWF, free TFPI, soluble thrombomodulin, and D-dimers (Table 2 ), but fibrinogen, soluble endothelial protein C receptor, and protein S activity did not differ among the 3 tertiles. The elevation in D-dimer levels was not accompanied by an increase in plasma levels of thrombin-antithrombin complexes.
Estradiol levels were not correlated with hemodynamics or hemostatic parameters in the total population or in the HRT user subgroup. However, current HRT was associated with a decrease in free TFPI levels (9.6Ϯ2.4 versus 11.8Ϯ3.2 ng/mL, Pϭ0.003), and this difference remained significant after adjustment for age (Pϭ0.03). Figure 1 represents the univariate correlations between free TFPI or vWF (y-axis) and PWV (x-axis). The most significant Using multiple regression analysis in the entire population, we further tested the relationship between PWV and both TFPI and vWF by also including age and HRT in the multivariate model (Table 3 ). This analysis showed that PWV was independently associated with free TFPI and vWF and accounted for 5.4% and 3.1% of the variations in free TFPI and vWF, respectively. The total model explained 23.0% of the free TFPI variation and 19.4% of the variation in vWF.
Correlation Between Coagulation Factors and Arterial Stiffness
When including fibrinogen, carotid PP, risk factors, or treatments in this model, the same parameters remained independently associated between PWV and free TFPI. On the contrary, when the same parameters were included in analysis of the association between PWV and vWF levels, the significance of the correlation disappeared. Nevertheless, a significant, positive correlation between carotid PP and vWF remained (Pϭ0.01). Figure 2 shows the effects of mechanical stretch on TFPI synthesis and release by cultured human VSMCs. When VSMCs were subjected to 5% cyclic stretch at a frequency of 1 Hz, there was no significant increase in TFPI gene expression (Figure 2A) . At the protein level, there was a significant increase in TFPI protein content, including cell-associated TFPI and total and free TFPI released into the cell supernatant. We further examined the effects of 10% of cyclic stretch ( Figure 2B ). TFPI mRNA levels were increased as early as 1 hour and remained elevated until 48 hours. The changes in TFPI mRNA levels included similar changes in all 3 forms of TFPI, which were higher than in VSMCs exposed to 5% cyclic stretch.
In Vitro Experiments
To determine whether pulsatility plays a role in mechanical stimulation of VSMCs, cells were exposed to 5% static stretch, the mean amplitude of the 10% cyclic stretch. As shown in Figure 2C , no significant difference was observed in TFPI production at any time point studied in response to static stretch.
Because the expression and release of TFPI is upregulated in dedifferentiated rat smooth muscle cells in culture, we examined whether the mRNA and protein levels of specific VSMC markers, ie, smooth muscle myosin heavy chain and smoothelin, were altered by cyclic mechanical stretch (Supplemental Figure  I) . When cells were exposed to 10% cyclic stretch, there was a time-dependent increase in the expression of smooth muscle myosin heavy chain and smoothelin genes. No modifications of these markers were detected at the protein level.
To investigate a distinctive impact of cyclic mechanical stretch on VSMCs and ECs, human cultured ECs were exposed to 5% or 10% cyclic stretch (Supplemental Figure   Figure 1 . Relationship between arterial stiffness and hemostatic parameters. Statistically significant correlations between free TFPI and PWV (rϭ0.366; PϽ0.0001) and between vWF and PWV (rϭ0.287; Pϭ0.001) were observed. II). Cell-associated TFPI and secreted TFPI were increased in a time-dependent and amplitude-dependent manner. At 10% cyclic stretch, the increase in all forms of TFPI was accompanied by an increase of TFPI mRNA. In contrast to VSMCs, the effect was significant only at 48 hours, and the overall response was markedly lower. There was also an amplitudedependent increase in vWF antigen levels at 24 and 48 hours in response to cyclic stretch.
Discussion
Our data demonstrate a coupling between vascular stiffening and several procoagulant and anticoagulant factors in postmenopausal women. The most important result, which is not explained by age per se, is the positive relationship between circulating free TFPI and arterial stiffness or PP (brachial or carotid). Circulating vWF was also associated with PWV, as previously reported, 19 but the correlation disappeared after adjustment to PP. In vitro experiments demonstrated for the first time the crucial role of pulsatile hemodynamics on the production and secretion of TFPI by VSMCs. Our population was principally characterized by an increase in PP (carotid and brachial) and PWV with age, accompanied by a trend toward an attenuation of PP amplification, whereas MAP and circumferential wall stress did not change. According to the recently proposed reference values of aortic PWV in the elderly using the same measurement device, 20 27% of subjects had high normal values, and 9% had elevated PWV. Thus, these data are consistent with a significant impairment of pulsatile hemodynamics with advancing age.
To understand our findings, it is important to recall that the vascular wall is one of the major contributors to the thrombotic response, in part via the production of vWF and TFPI. 21 Aging causes well-described structural and molecular rearrangements of the vascular wall leading to arterial stiffening. This parameter depends mainly on the structure of the media and less on the endothelium. [22] [23] [24] [25] [26] The correlation between free TFPI levels and PWV was likely related to the global alterations of the vascular wall, a finding previously suggested for coronary artery disease by Morange et al and indicated by the presence of a positive correlation between TFPI and wall stress. 27 In the present study, free TFPI and vWF plasma concentrations were significantly associated with PWV when controlling solely for age and HRT. The association between free TFPI and PWV was still significant after adjustment for potential confounders, such as fibrinogen, CV risk factors or drug treatments, and above all for PP. In contrast, carotid PP but not PWV was independently associated with vWF when all these factors were considered. These results suggest the involvement of pulsatile components of blood pressure and vascular wall stiffness in determining plasma levels of free TFPI and confirm that circulating vWF levels are somewhat dependent on pulsatile pressure 28 in addition to the predominant role of flow. 29 The first part of this work was a cross-sectional in vivo study in a human population and could not establish a causal link between TFPI and arterial stiffness. Although vWF is produced almost exclusively by ECs, other vascular wall cells constitutively synthesize TFPI, particularly smooth muscle cells, at a level equivalent to that of ECs. 30, 31 Plasma TFPI exists in several forms, both full-length and truncated forms, 32 but the inability to assay cellular TFPI in patients explains why we cannot determine whether these different forms originate from different vascular cell types. Therefore, we designed the second part of the study to explore in vitro the direct effects of pulsatile hemodynamics on TFPI expression in VSMCs and ECs.
The present study describes a previously unrecognized increase in TFPI synthesis and secretion induced by mechanical pulsatile forces. Upregulation of TFPI expression in VSMCs by growth factors, as well as by changes of cell phenotype toward a synthetic state, has been reported in a few experimental studies. 31, 33, 34 The effects of inflammatory processes are more complex, because it has been reported that they induced either no modification 34 or a decreased expression of TFPI. 35 Our results provide evidence that cyclic stretch induced an increase in TFPI synthesis and secretion by VSMCs, whereas no changes were observed in cells exposed to static stretch. The response occurred early and was unaltered over time but was dependent on the amplitude of cyclic stretch. It is likely that the mechanical pulsatile stretch applied with the Flexercell system produced effects similar to the pulsatile stresses exerted on VSMCs in situ. Parallel increases in TFPI mRNA and protein levels in cultured VSMCs also suggest that control of TFPI expression by mechanical stress occurs both via transcriptional and translational regulations. We also demonstrate that the increase in TFPI under cyclic stretch was not due to modifications of the cellular phenotype toward a dedifferentiated state. Although ECs have been thought to be the primary source of TFPI within the vasculature, our findings indicate that cultured ECs were less sensitive to cyclic stretch-mediated increases in TFPI production than VSMCs exposed to an equivalent level of stretch. Finally, our data provide experimental evidence that pulsatility is necessary and sufficient to modulate VSMC TFPI expression, suggesting that changes in free TFPI plasma levels in our population mainly originated from the smooth muscle cells of the vascular wall. The higher amount of TFPI, both total and free forms, within the arterial media induces changes in the biology of the VSMC membrane that could play a role in the regulation of thrombosis triggered by endothelial denudation. This suggests a direct relationship of TFPI with aortic stiffness, which is in agreement with the independent association of plasma levels of free TFPI with PWV in our population. In the same way, modulation of vWF in stretched ECs provides an explanation for the clinical association between PP and vWF. Increases in TFPI and vWF occurred in parallel and thus may compensate for each other because these 2 molecules have opposite effects on the coagulation process (anti-and procoagulant effects, respectively). Using DNA microarray techniques, it has been demonstrated that cyclic strain in human cultured VSMCs changes the expression of several genes, including those encoding anticoagulant factors. 36 This highlights that the interaction between pulsatile signals and selected procoagulant and anticoagulant factors originating from the vascular wall should be investigated further both in vivo and in vitro. Clinical studies have shown that coronary mortality can be predicted not only by brachial and carotid PP but also by carotid distension. 37 One potential limitation of our study is that we analyzed a population selected with regard to gender and the absence of overt CV disease, and so our findings cannot be extrapolated to male subjects or patients identified as being at higher CV risk. However, it has previously been shown that the increase with age of the components of the tissue factor coagulation pathway is mainly due to the contribution of the female part of the normal population. 38 In line with our results, it has been reported that free TFPI decreased with HRT use, and this was consistently true for oral regimens, 39 -41 whereas it was more debated for transdermal therapy. 42, 43 Several groups of investigators were cautious in suggesting favorable effects of administered estrogen on PWV. 44 Here we show that the correlation between free TFPI and PWV remains significant even when excluding women currently on HRT, in particular those on oral HRT, indicating that this correlation is not dependent on HRT effects.
In conclusion, in postmenopausal women older than 60 and free of any target organ damage, we report a correlation between increased PWV or PP and circulating free TFPI, indicating that free TFPI increases as vascular wall function deteriorates. The relationship between TFPI and pulsatile stretch in cultured VSMCs supports this clinical finding and provides a possible mechanistic link between arterial stiffness and coagulation proteins in our population. The pathophysiological relevance of increased plasma levels of free TFPI for CV death in patients with coronary artery disease has previously been underlined. 27 In view of these findings, it would be of great interest to set up a longitudinal study to establish the predictive value of free TFPI with respect to the occurrence of CV events in patients with increased arterial stiffness. . TFPI synthesis and secretion by cultured human aortic VSMCs exposed to mechanical stretch. VSMCs grown on collagen-coated silicone elastomer-bottomed plates were subjected to 5% (A) or 10% (B) cyclic or to 5% static (C) mechanical stretch. Results (meansϮSEM of 3 experiments performed in duplicate) are expressed as ratios of values obtained in stretched cells (S) to those obtained with control (unstretched) cells (NS) at each time point studied. Cell TFPI indicates TFPI in cell lysates; TFPI and f-TFPI, total TFPI and free TFPI in conditioned medium, respectively. *PϽ0.05 vs a ratio value of 1; †PϽ0.05 vs 5% cyclic stretch.
